Risk factors and diagnostic significance of the N-terminal pro-brain natriuretic peptide as a marker in patients with acute decompensated heart failure and diabetic kidney disease

QR Code

Risk factors and diagnostic significance of the N-terminal pro-brain natriuretic peptide as a marker in patients with acute decompensated heart failure and diabetic kidney disease

Aim. To assess the risk factors and diagnostic significance of the N-terminal probrain natriuretic peptide (NT-proBNP) in patients with acute decompensated heart failure (ADHF) and diabetic kidney disease (DKD).Material and methods. A total of 125 patients with ADHF and type 2 diabetes (T2D) were ex...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. A. Koziolova, A. S. Veklich
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2021-04-01
Series:	Российский кардиологический журнал
Subjects:	natriuretic peptide acute decompensated heart failure diabetic kidney disease
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4337
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

N-terminal pro-brain natriuretic peptide in essential arterial hypertension patients: antihypertensive therapy effects
by: A. S. Galyavich, et al.
Published: (2006-10-01)

Association of genetic polymorphisms of brain natriuretic peptide with cardiovascular diseases
by: A. Ya. Panarina, et al.
Published: (2024-11-01)

Risk factors and diagnostic value of urinary N-terminal pro-brain natriuretic peptide for verification of heart failure in human immunodeficiency virus-infected patients
by: O. G. Goryacheva, et al.
Published: (2022-03-01)

Point-of-care N-terminal pro-brain natriuretic peptide testing in patients with heart failure: data from the DREAM study
by: F. I. Belyalov, et al.
Published: (2024-06-01)

Evaluation N-terminal pro-B-type natriuretic peptide and other biochemical parameters in heart failure with or without chronic kidney disease in Kirkuk city
by: Firas Tariq, et al.
Published: (2024-10-01)

GENDER AND AGE DIFFERENCES OF BRAIN NATRIURETIC PEPTIDE CONCENTRATION IN PATIENTS WITH MYOCARDIAL INFARCTION
by: E. N. Usoltseva, et al.
Published: (2014-07-01)

Role of brain natriuretic peptide in the pathogenesis of resistant hypertension
by: K. Yu. Nikolaev, et al.
Published: (2023-02-01)

The level of Brain natriuretic Peptide as a Predictor of the Postoperative Period at Operations with Artificial Blood circulation
by: Yu. A. Bakhareva, et al.
Published: (2019-01-01)

N-terminal Pro-B-Type Natriuretic Peptide is a Myocardial Biomarker in Pulmonary Sepsis and Septic Shock
by: I. N. Tyurin, et al.
Published: (2022-10-01)

NEW POSSIBILITIES FOR EVALUATION OF SEVERITY AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE BASED ON N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE PLASMA LEVEL
by: A. S. Galjavich, et al.
Published: (2016-01-01)

Effect of dapagliflozin on serum N‐terminal fragment-proB‐type natriuretic peptide level in patient with acute decompensated heart failure
by: Hanna Jassim Dohei, et al.
Published: (2025-03-01)

Modification of the Association of B-Type Natriuretic Peptides With Mortality and Hospitalization Outcomes by Sex
by: David Bobrowski, MD, et al.
Published: (2025-08-01)

The level of N-terminal pro-brain natriuretic peptide depending on vascular wall condition and bone mass in postmenopausal women
by: I. A. Skripnikova, et al.
Published: (2020-07-01)

Endothelium-derived C-type natriuretic peptide offsets the pathogenesis of pulmonary hypertension
by: Joshua P. Dignam, et al.
Published: (2025-09-01)

Brain natriuretic peptide and all-cause mortality in patients treated with haemodialysis
by: Maria K Svensson, et al.
Published: (2025-06-01)

Assessment of glomerular and tubulointerstitial apparatus state depending on the level of the natriuretic peptide in hypertension patients
by: A. I. Chernyavina
Published: (2020-04-01)

BRAIN NATRIURETIC PEPTIDE AS BIOCHEMICAL MARKER FOR STRUCTURAL AND FUNCTIONAL HEART DISORDERS IN ARTERIAL HYPERTENSION
by: S. V. Ivanova, et al.
Published: (2015-12-01)

Natriuretic peptides and chronic heart failure in arterial hypertension patients
by: Yu. A. Vasuyk, et al.
Published: (2007-04-01)

NATRIURETIC PEPTIDE AND HIS PROGENITORS AS PREDICTORS OF PROGRESSIVE POSTOPERATIVE LEFT VENTRICLE REMODELING IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY
by: S. S. Gutor, et al.
Published: (2013-12-01)

INTEGRATION OF BIOMARKERS INTO THE PRACTICE OF TREATING PATIENTS WITH HEART FAILURE: THE ROLE OF DETERMINING THE BLOOD LEVEL OF NATRIURETIC PEPTIDES
by: S. R. Gilyarevskiy, et al.
Published: (2017-12-01)

Natriuretic peptides: new challenges — new solutions
by: O. M. Drapkina, et al.
Published: (2021-11-01)

CLINICAL SIGNIFICANCE OF DETERMINING THE LEVEL OF THE BRAIN NATRIURETIC PEPTIDE FOR THE DIAGNOSIS OF HEART FAILURE OF COMORBID PATIENTS WITH CORONARY HEART DISEASE AND THYROTOXICOSIS
by: E. V. Pashchenko, et al.
Published: (2017-09-01)

Integral assessment of congestion in patients with acute decompensated heart failure
by: Zh. D. Kobalava, et al.
Published: (2022-03-01)

CLINICAL SIGNIFICANCE OF N-TERMINAL FRAGMENT OF NATRIURETIC PEPTIDE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO DO NOT RECEIVE PATHOGENETIC THERAPY
by: T. A. Panafidina, et al.
Published: (2017-09-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

B-type natriuretic peptide informativeness in myocardial revascularization with cardio-pulmonary bypass
by: I. A. Kozlov, et al.
Published: (2024-08-01)

Predictive value of brain natriuretic peptide for cardiovascular risk assessment in non-cardiac surgery
by: O. N. Dzhioeva, et al.
Published: (2020-11-01)

The Role of Natriuretic Peptides in Management of Premature Infants with Hemodynamically Significant Patent Arterial Duct
by: Evgenij G. Furman, et al.
Published: (2019-04-01)

Risk factors for acute decompensated heart failure in type 2 diabetes patients
by: N. A. Koziolova, et al.
Published: (2020-05-01)

EFFECTIVENESS OF PHARMACOTHERAPY FOR NORMALIZATION OF THE BRAIN NATRIURETIC PEPTIDE, RENINE-ANGIOTENSINALDOSTERONE SYSTEM ACTIVATION AFTER SURGICAL REVASCULARIZATION OF MYOCARDIUM IN POSTINFARCTION CARDIOSCLEROSIS PATIENTS
by: S. A. Kovalev, et al.
Published: (2016-12-01)

Increased B-type Natriuretic Peptide (NT-proBNP) Level as a Risk Factor in Cardiosurgical Patients
by: I. A. Kozlov, et al.
Published: (2010-02-01)

Efficiency of meldonium application in complex treatment of patients with chronic heart failure decompensation
by: A. S. Sycheva, et al.
Published: (2021-06-01)

The Diagnostic Utility of Brain Natriuretic Peptide in Heart Failure Patients Presenting with Acute Dyspnea: A Systematic Review and Meta-analysis
by: Mohammad Amin Karimi, et al.
Published: (2025-07-01)

N-TERMINAL BRAIN NATRIURETIC PROPEPTIDE AS A MARKER OF MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: O. L. Barbarash, et al.
Published: (2012-06-01)

Increased natriuretic peptides not associated with heart failure
by: A. M. Chaulin, et al.
Published: (2021-01-01)

Associations of elevated levels of brain natriuretic peptide and heart failure and their contribution to survival in the Russian middle-aged population: data from the ESSE-RF study
by: S. A. Shalnova, et al.
Published: (2023-07-01)

THE ROLE OF N-TERMINAL PRO-C-TYPE NATRIURETIC PEPTIDE AS A DIAGNOSTIC BIOMARKER OF PULMONARY HYPERTENSION IN COPD PATIENTS
by: V. V. Gaynitdinova, et al.
Published: (2015-12-01)

The Perioperative Changes in and Clinical Value of B-type Natriuretic Peptide Levels in the Blood of Cardiosurgical Patients
by: I. A. Kozlov, et al.
Published: (2012-08-01)

Parallels of structural-functional parameters the myocardium, C-type natriuretic peptide and endothelin-1 plasma concentrations in women with uncomplicated essential hypertension
by: V. V. Petrovska, et al.
Published: (2014-12-01)

Diagnostic value of N-terminal pro-B-type natriuretic peptide in hemodialysis patients
by: D. S. Sedov, et al.
Published: (2020-02-01)